Alkem Laboratories Ltd

According to an exchange filing, Olesoft Trucera contains N-Palmitoyl Serinol, which stimulates the skin's natural ceramide production, a potent blend of five ceramides to lock in moisture and support the skin barrier's function, and dual oat-extract actives along with Niacinamide to provide anti-inflammatory benefits. Olesoft Trucera will be available on prescription. Commenting on the launch, Dr Vikas Gupta, chief executive officer, Alkem, said, 'Indian consumers are increasingly seeking advanced skincare regimens with products that are clinically validated and contain high-performance actives. Alkem is strengthening its presence in this space with differentiated, evidence-backed solutions that address patient needs. The launch of Olesoft Trucera reflects this approach, combining science and clinical insights to offer a meaningful option for long-term skin barrier repair and lasting protection against moisture loss. This is also part of Alkem's broader strategy to focus on smart product selection in high-growth therapy areas.' Alkem Laboratories is engaged in the pharmaceutical business with global operations. The company is engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company's consolidated net profit jumped 21.8% to Rs 664.26 crore in Q1 FY26 as compared with Rs 545.16 crore posted in Q1 FY25. Net sales rose 11.2% YoY to Rs 3,371.14 crore in the quarter ended 30 June 2025. The scrip rose 0.79% to currently trade at Rs 5,391 on the BSE. Powered by Capital Market - Live

Alkem Laboratories announced the launch of Olesoft Trucera moisturizing lotion, an advanced science-led formulation designed to restore hydration, strengthen the skin barrier, and soothe skin flare ups with an inside out approach. Olesoft Trucera contains N-Palmitoyl Serinol that stimulates the skin's natural ceramide production, a potent blend of five ceramides to lock in moisture and support the skin barrier's function, and dual oat-extract actives along with Niacinamide to provide anti-inflammatory benefits. Olesoft Trucera will be available on prescription, so consult a doctor before using. Powered by Capital Market - Live

Alkem Laboratories Ltd is up for a third straight session in a row. The stock is quoting at Rs 5375, up 4.39% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.56% on the day, quoting at 24624.55. The Sensex is at 80559.71, up 0.4%. Alkem Laboratories Ltd has added around 11.04% in last one month. Meanwhile, Nifty Pharma index of which Alkem Laboratories Ltd is a constituent, has added around 1.12% in last one month and is currently quoting at 21753.5, up 1.87% on the day. The volume in the stock stood at 6.88 lakh shares today, compared to the daily average of 1.35 lakh shares in last one month. The benchmark August futures contract for the stock is quoting at Rs 5393.5, up 4.29% on the day. Alkem Laboratories Ltd is down 5.41% in last one year as compared to a 1.99% gain in NIFTY and a 0.67% gain in the Nifty Pharma index.The PE of the stock is 27.05 based on TTM earnings ending March 25.Powered by Capital Market - Live

Alkem Laboratories has, pursuant to a shareholders' agreement dated 12 August, 2025, agreed to incorporate a subsidiary company in the Kingdom of Saudi Arabia. Pursuant to incorporation of such subsidiary, the Company will hold 51% of the total share capital. The balance stake of 49% will be held by Abdulaziz Alsheikh (Saudi Partner). The subsidiary is proposed to be incorporated as a limited liability company and will be involved in the manufacture, import, marketing and distribution of pharmaceutical and/or nutraceutical products within the Kingdom of Saudi Arabia. Powered by Capital Market - Live

Net profit of Alkem Laboratories rose 21.85% to Rs 664.26 crore in the quarter ended June 2025 as against Rs 545.16 crore during the previous quarter ended June 2024. Sales rose 11.19% to Rs 3371.14 crore in the quarter ended June 2025 as against Rs 3031.82 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales3371.143031.82 11 OPM %21.9220.08 - PBDT845.76699.84 21 PBT758.08619.36 22 NP664.26545.16 22 Powered by Capital Market - Live

Alkem Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live

Alkem Laboratories Ltd is up for a fifth straight session today. The stock is quoting at Rs 5065.4, up 0.36% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.07% on the day, quoting at 24697.95. The Sensex is at 80903.8, up 0.02%. Alkem Laboratories Ltd has gained around 2.56% in last one month. Meanwhile, Nifty Pharma index of which Alkem Laboratories Ltd is a constituent, has gained around 4.31% in last one month and is currently quoting at 22761.15, up 1% on the day. The volume in the stock stood at 30458 shares today, compared to the daily average of 1.18 lakh shares in last one month. The benchmark July futures contract for the stock is quoting at Rs 5083, up 0.67% on the day. Alkem Laboratories Ltd is down 3.08% in last one year as compared to a 0.64% slide in NIFTY and a 6.72% slide in the Nifty Pharma index.The PE of the stock is 26.51 based on TTM earnings ending March 25.Powered by Capital Market - Live

Alkem Laboratories Ltd gained for a fifth straight session today. The stock is quoting at Rs 5019, up 0.34% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.07% on the day, quoting at 25193.55. The Sensex is at 82521.43, down 0.14%. Alkem Laboratories Ltd has gained around 4.45% in last one month. Meanwhile, Nifty Pharma index of which Alkem Laboratories Ltd is a constituent, has gained around 5.37% in last one month and is currently quoting at 22593.9, up 0.68% on the day. The volume in the stock stood at 46845 shares today, compared to the daily average of 1.78 lakh shares in last one month. The benchmark July futures contract for the stock is quoting at Rs 5029.4, up 0.18% on the day. Alkem Laboratories Ltd is down 4.81% in last one year as compared to a 1.58% jump in NIFTY and a 9.53% jump in the Nifty Pharma index.The PE of the stock is 28.61 based on TTM earnings ending March 25.Powered by Capital Market - Live

Alkem Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 4900.8, up 1.24% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.53% on the day, quoting at 25214. The Sensex is at 82662.59, up 0.5%. Alkem Laboratories Ltd has risen around 0.67% in last one month. Meanwhile, Nifty Pharma index of which Alkem Laboratories Ltd is a constituent, has risen around 2.68% in last one month and is currently quoting at 22410.35, up 0.98% on the day. The volume in the stock stood at 1.14 lakh shares today, compared to the daily average of 1.65 lakh shares in last one month. The benchmark July futures contract for the stock is quoting at Rs 4913.8, up 1.24% on the day. Alkem Laboratories Ltd is down 7.48% in last one year as compared to a 2.44% spurt in NIFTY and a 8.98% spurt in the Nifty Pharma index.The PE of the stock is 27.7 based on TTM earnings ending March 25.Powered by Capital Market - Live

Alkem Laboratories Ltd is up for a third straight session today. The stock is quoting at Rs 4975, up 2.08% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.12% on the day, quoting at 25133.1. The Sensex is at 82476.63, up 0.04%. Alkem Laboratories Ltd has slipped around 0.91% in last one month. Meanwhile, Nifty Pharma index of which Alkem Laboratories Ltd is a constituent, has slipped around 3.86% in last one month and is currently quoting at 21826.8, up 0.42% on the day. The volume in the stock stood at 1.76 lakh shares today, compared to the daily average of 1.93 lakh shares in last one month. The benchmark June futures contract for the stock is quoting at Rs 4995.5, up 2.03% on the day. Alkem Laboratories Ltd is down 1.81% in last one year as compared to a 8.03% jump in NIFTY and a 11.32% jump in the Nifty Pharma index.The PE of the stock is 27.89 based on TTM earnings ending March 25.Powered by Capital Market - Live